Persistent swollen neck glands could be suspicious for cancer
the ONA take:
Patients with persistent unexplained swollen neck glands should be referred for specialist investigations, according to two reports from University of Exeter Medical School, in the United Kingdom. Such referrals could save thousands of death each year from lymphoma.
Latest available figures from 1995 to 1999 show that more than 6,320 deaths were avoidable during that period. In addition, more than 40% of patients had visited their GP with symptoms three or more times before being referred for cancer investigations.
Both reports used data from UK primary care patient records from the Clinical Practice Research Datalink (CPRD), focusing on patients older than 40 years.
The two reports produced similar results. The researchers conclude that the risk that persistent swollen glands are indicative of cancer is higher than previously thought, and primary care providers should consider referring these patients to a specialist earlier.
Patients with persistent unexplained swollen neck glands should be referred for specialist investigations.
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Immunotherapy and the Future of Prostate Cancer Treatment
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- E-cigarettes and Replacement Nicotine Therapy Safer Than Tobacco Use
- Patients With Urologic Cancer Need Psycho-oncologic Support to Manage High Stress
- Lung Cancer Screening Rates Low Among Present and Former Smokers
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Patients Undergoing Multiple Systemic Therapies for Metastatic Prostate Cancer Expect a Cure
- FDA Grants Priority Review to Ceritinib for First-line Treatment of ALK+ NSCLC
- Overall Health Worse in African American Men Undergoing Active Surveillance For Prostate Cancer
- Clinical Benefit of Simtuzumab Inconsistent for Myelofibrosis
- Follow-up Rates in Active Surveillance for Prostate Cancer Higher in University-Based vs Safety-Net Hospitals
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|